3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Classical hematology
1
Conditions
Ovarian Neoplasms
1
Fanconi Anemia, Complementation Group D1
1
Interventions
olaparib
9
Carboplatin
3
talazoparib
1
pembrolizumab
1
liposomal doxorubicin
1
iniparib
1
Trabectedin
1
Surveys and Questionnaires
1
Secretin
1
Paclitaxel
1
Genotype
1
Genetic Counseling
1
Demography
1
Data Collection
1
Counseling
1
Cognitive Behavioral Therapy
1
Biopsy, Fine-Needle
1
ABT-767
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Fanconi Anemia, Complementation Group D1
×
liposomal doxorubicin
×
Classical hematology
×
Clear all
NCT00628251
2019-12-05
ICEBERG 3
AstraZeneca
Phase 2
Completed
97 enrolled
22 charts